Actuate Therapeutics, Inc. Common stock share price logo

Actuate Therapeutics, Inc. Common stock

NASDAQ: ACTU

Small Cap

$3.06

+0.11

(+3.73%)

as on

Actuate Therapeutics, Inc. Common stock Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    $2.81
    $3.06
    downward going graph

    8.17%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.58
    $11.99
    downward going graph

    48.37%

    Downside

    291.83%

    Upside

    downward going graph

Actuate Therapeutics, Inc. Common stock share price movements today

Previous Close
$2.95
Open
$2.92
Volume
157.7K
Day's Low - High
$2.81 - $3.06
52 Week Low - High
$1.58 - $11.99

Actuate Therapeutics, Inc. Common stock Historical Returns

1 Month Return
+ 46.19 %
3 Month Return
-30.39 %
1 Year Return
-66.67 %
3 Year Return
0 %
5 Year Return
0 %

Actuate Therapeutics, Inc. Common stock Stock Fundamentals & Key Indicators

Check Actuate Therapeutics, Inc. Common stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$69.9M

EPS (TTM)

-0.73

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-553.75%

Actuate Therapeutics, Inc. Common stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Actuate Therapeutics, Inc. Common stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$69.9MNANA0.00%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Actuate Therapeutics, Inc. Common stock Stock including INR - Dollar returns

The Actuate Therapeutics, Inc. Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Actuate Therapeutics, Inc. Common stock investment value today

Current value as on today

₹37,291

Returns

-₹62,709

(-62.71%)

Returns from Actuate Therapeutics, Inc. Common stock Stock

-₹66,775 (-66.78%)

Dollar Impact

₹4,066 (+4.07%)

Actuate Therapeutics, Inc. Common stock Stock’s Investor Sentiment and Interest

Search interest for Actuate Therapeutics, Inc. Common stock Stock has increased by 61% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:61% versus previous 30 day period

Actuate Therapeutics, Inc. Common stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-6
-7
-7
-5
-5
-6
-6
-5
-5
-4
EBITDA
-6
-7
-8
-6
-5
-6
-6
-5
-5
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-6
-7
-8
-6
-5
-6
-6
-5
-5
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
0
Net Income
-6
-7
-8
-6
-5
-6
-6
-5
-5
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Actuate Therapeutics, Inc. Common stock Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-20
-24
-25
-22
EBITDA
-20
-24
-25
-22
Interest Expense
0
0
0
0
Depreciation
-
-
-
-
Income Before Tax
-20
-24
-27
-22
Income Tax Expense
-
-
0
0
Net Income
-20
-24
-27
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Actuate Therapeutics, Inc. Common stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-7
-8
-6
-5
-6
-6
-5
-5
-4
Operating Cash Flow
-5
-5
-2
-9
-4
-4
-4
-6
-3
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
4
0
22
0
0
6
17
0
Change in Cash
-5
0
-1
13
-4
-4
2
10
-3

Actuate Therapeutics, Inc. Common stock Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-27
-22
Operating Cash Flow
-21
-21
-19
Investing Cash Flow
-
-
-
Financing Cash Flow
4
27
23
Change in Cash
-17
5
4

Insights on Actuate Therapeutics, Inc. Common stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ACTU stock has moved up by 46.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 25.7% return, outperforming this stock by 92.4%

About Actuate Therapeutics, Inc. Common stock

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as neuroblastoma and pediatric leukemias. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.
OrganisationActuate Therapeutics, Inc. Common stock
Headquarters1751 River Run, Fort Worth, TX, United States, 76107
IndustryBiotechnology
CEOMr. Daniel M. Schmitt
E-voting on sharesClick here to vote

Key Management of Actuate Therapeutics, Inc. Common stock

Name

Title

Mr. Daniel M. Schmitt

CEO, President & Director

Dr. Andrew P. Mazar Ph.D.

Co-Founder & COO

Mr. Paul J. Lytle CPA

Chief Financial Officer

Dr. Alan Kozikowski Ph.D.

Scientific Founder and Advisor

FAQs

What is Actuate Therapeutics, Inc. Common stock share price today?

Actuate Therapeutics, Inc. Common stock share price today is $3.06 as on at the close of the market. Actuate Therapeutics, Inc. Common stock share today touched a day high of $3.06 and a low of $2.81.

What is the 52 week high and 52 week low for Actuate Therapeutics, Inc. Common stock share?

Actuate Therapeutics, Inc. Common stock share touched a 52 week high of $11.99 on and a 52 week low of $1.58 on . Actuate Therapeutics, Inc. Common stock stock price today i.e. is closed at $3.06,which is 74.48% down from its 52 week high and 93.67% up from its 52 week low.

What is Actuate Therapeutics, Inc. Common stock's market capitalisation today?

Actuate Therapeutics, Inc. Common stock market capitalisation is $0.00T as on .

How to invest in Actuate Therapeutics, Inc. Common stock Stock (ACTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Actuate Therapeutics, Inc. Common stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Actuate Therapeutics, Inc. Common stock Shares that will get you 0.4902 shares as per Actuate Therapeutics, Inc. Common stock share price of $3.06 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Actuate Therapeutics, Inc. Common stock Stock (ACTU) from India?

Indian investors can start investing in Actuate Therapeutics, Inc. Common stock (ACTU) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Actuate Therapeutics, Inc. Common stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Actuate Therapeutics, Inc. Common stock share’s latest price of $3.06 as on May 6, 2026 at 1:29 am IST, you will get 3.2680 shares of Actuate Therapeutics, Inc. Common stock. Learn more about fractional shares .